Compounded Semaglutide vs Brand Name Wegovy: What the FDA and Studies Say About Safety

With brand name GLP-1 medications costing $900-$1,300 per month without insurance, compounded semaglutide and tirzepatide have become extremely popular. But how safe are they? Here is what the FDA, clinical studies, and regulatory agencies have to say. What Is Compounded Semaglutide? Compounded semaglutide is not FDA-approved. It is produced by licensed compounding pharmacies using semaglutide … Read more

GLP-1 Side Effects: What Clinical Studies Reveal About Safety and Tolerability

All medications have side effects, and GLP-1 receptor agonists are no exception. But what does the actual clinical trial data say about how common, how severe, and how manageable these side effects are? Most Common Side Effects Across all major GLP-1 trials, gastrointestinal side effects are the most common. Here is the data from the … Read more

SELECT Trial: Semaglutide Cuts Heart Attack Risk by 20% — Landmark Study Explained

The SELECT trial is one of the most important studies in obesity medicine. Published in the New England Journal of Medicine in November 2023 (Lincoff et al., NEJM 2023;389:2221-2232), this landmark trial showed that semaglutide 2.4 mg (Wegovy) reduces cardiovascular risk in people with obesity — even if they do not have diabetes. What the … Read more

How Much Weight Can You Actually Lose on GLP-1 Medications? 6-Month and 12-Month Data

If you are considering a GLP-1 medication for weight loss, the most important question is: how much weight will I actually lose? Here is what the clinical trial data says at 3 months, 6 months, and 12+ months. Wegovy (Semaglutide 2.4 mg) — STEP Program Results The STEP clinical trial program included four phase 3 … Read more

Mounjaro vs Ozempic vs Wegovy vs Zepbound: Which GLP-1 Drug Is Best for Weight Loss?

Four GLP-1 drugs dominate the weight loss market in 2026: Wegovy (semaglutide), Zepbound (tirzepatide), Mounjaro (tirzepatide, approved for diabetes), and Ozempic (semaglutide, approved for diabetes but used off-label for weight loss). Here is what the clinical trials actually show. How They Work Semaglutide (Ozempic/Wegovy) is a GLP-1 receptor agonist. It mimics the GLP-1 hormone that … Read more